查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1466008

药物输送控制释放市场：按释放机制、技术和应用划分 - 2024-2030 年全球预测

Controlled Release Drug Delivery Market by Release Mechanism, Technology, Application - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年控释控制释放市场规模为430.7亿美元，预估2024年将达467亿美元，2030年将达796.2亿美元，复合年增长率为9.17%。

控制释放药物递送是指以可预测且可控制的速率释放药物活性成分的系统。这种药物输送方法可以稳定血液中的药物水平，减少给药频率，并提高患者的依从性。控制释放药物输送市场是由在各种应用和最终使用场景中实现这些目标的产品和技术定义的。控制释放药物传递的应用涵盖多个治疗领域，包括糖尿病、心血管疾病、中枢神经系统疾病、疼痛管理和肿瘤学。影响控制释放药物递送市场成长的挑战包括与开发新药物递送系统相关的高成本以及为特定药物配製控制释放药物递送系统的技术挑战。市场正在见证精准医疗方法的进步，这些方法能够创建适合个别患者需求的药物输送系统。此外，新兴市场的势头明显，医疗保健基础设施的扩大和药物取得的改善正在为控制释放技术创造新的机会。此外，製药公司和药物传输技术公司之间的策略合作伙伴关係正在透过促进创新和开发复杂且更有效的药物输送机制来重塑格局。

主要市场统计
基准年[2023] 430.7亿美元
预测年份 [2024] 467亿美元
预测年份 [2030] 796.2亿美元
复合年增长率（%） 9.17%

释放机制：增加研发活动以开发强大的化学活化系统

活化调节的药物递送系统旨在在外部或内部触发因素（例如磁场、超音波、pH 变化和酶）的刺激下释放药物。这些系统可以精确控制药物的释放曲线，特别有利于靶向体内的特定部位以减少全身副作用。化学活化系统依靠特定的化学反应来触发药物释放，例如特定酶的存在或 pH 水平的变化。这些系统适用于胃肠道治疗，因为它们可以调节以激活胃肠道的不同部位。回馈控制系统利用生物或化学反应来控制药物释放。依生理需求即时调整药物释放，促进个人化医疗。此类系统通常包括与药物输送装置整合的感测器。微储库系统由多个小室（储库）组成，其中含有受控时间间隔或特定触发器释放的药物。这种方法允许具有不同释放曲线的多种药物递送，并且对于复杂的给药方案非常有用。基于聚合物的药物传递系统利用生物分解性的聚合物来封装药物，并随着聚合物的降解缓慢释放药物。这些系统释放週期长，适用于慢性疾病。

整合标靶递送，提高技术治疗指数，减少副作用

凝聚是将胶体溶液分离成两个不同的液相的过程：富含聚合物的凝聚相和缺乏聚合物的上清液。该技术用于封装药物，以保护它们免受环境劣化并控制释放。当活性成分对劣化敏感且需要保护屏障时优先使用。植入是医疗设备，旨在在较长时间内将治疗剂直接释放到作用部位。当需要局部和持续的药物传输时使用它，例如在肿瘤学和荷尔蒙补充疗法中。微胶囊化涉及用涂层封装微小颗粒或液滴，从而赋予微小胶囊有用的特性。标靶递送旨在透过将活性药物引导至体内的特定细胞和组织来提高治疗指数并减少副作用。当患病部位需要高药物浓度，同时最大限度地减少全身性药物暴露时（例如在癌症治疗中），该技术是首选。经经皮给药系统 (TDDS) 透过皮肤给药，为口服和注射提供了一种非侵入性且方便的替代方案。 TDDS 通常被选用于慢性疾病管理，其中连续给药具有优势。 Wurster 製程是流体化床包衣的子集，广泛应用于製药领域，对颗粒、丸剂和颗粒进行包衣，以实现控制释放。此方法适用于需要均匀包覆和精确控制释放动力学的药物。

应用实例 慢性病管理中越来越偏好注射控制释放给药系统

药物洗脱支架是心臟病学中使用的控制释放药物输送的一个突出例子。透过将药物合併到支架结构中，这些装置在血管成形术期间被放置到狭窄的冠状动脉中。随着时间的推移，药物会缓慢释放，防止手术后动脉血管再阻塞（血管再阻塞）。输液帮浦是医疗设备，旨在以受控方式将液体（包括营养物和药物）输送到患者体内。这些帮浦可用于各种医疗保健环境，包括医院、疗养院和家庭护理患者。能够控制药物传递的时间、速率和持续时间有助于维持血液中的治疗药物水平，这对于化疗、疼痛管理和抗生素给药等治疗至关重要。注射控制释放系统提供了一种先进的药物传递方法，特别是对于全身性效应和标靶治疗。这些系统通常使用封装的药物颗粒或生物分解性的聚合物，它们会随着时间的推移而分解，以指定的速率释放药物。定量吸入器是设计用于将特定量的药物输送到肺部的装置，通常用于治疗气喘和慢性阻塞性肺病等呼吸系统疾病。与全身给药相同的药物相比，MDI 的控制释放机制可确保精确剂量、快速起效并减少全身副作用，从而有效管理患者病情。口服药物递送是最常见的控制释放技术之一。它们有多种剂型，如锭剂、胶囊和薄膜，可控制药物从消化道释放和吸收的速率。经皮吸收贴片和眼用贴片代表了一类独特的控制释放药物传递系统。经皮吸收贴片透过皮肤输送药物，可以长时间稳定地释放药物，最大限度地减少尖峰时段波动并提高患者的舒适度。

区域洞察

由于大型製药公司和先进的医疗基础设施的存在，美洲（尤其是北美）的控制释放给药市场已十分成熟。由于 FDA 对新型药物输送系统的支持以及需要长期治疗的慢性病的高盛行率，美国在市场上占有重要地位。由于欧洲药品管理局 (EMA) 管理的强大法律规范，欧洲在药物输送控制释放市场中占有重要份额。市场受益于政府的医疗保健政策以及专利悬崖导致的学名药的崛起。由于经济发展、医疗基础设施投资以及先进治疗选择的增加，中东和非洲显示出成长潜力。由于中国和印度等国家製药业的扩张和医疗保健支出的增加，预计亚太地区控制释放领域将快速成长。解决许多患者未满足的医疗需求正受到越来越多的关注。国内外公司之间的合作以及政府对促进学名药使用的支持为该地区提供了成长机会。

FPNV定位矩阵

FPNV定位矩阵对于评估控释控制释放市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对控制释放市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告对以下几个方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4. 竞争评估和情报：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.控释控制释放市场的市场规模与预测是多少？

2.控释控制释放市场预测期间需要考虑投资的产品、细分市场、应用和领域有哪些？

3.控释控制释放市场的技术趋势与法规结构是什么？

4.控释控制释放市场主要厂商的市场占有率为何？

5. 进入控制释放市场的合适型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 婴幼儿和老年人对控制释放製剂的需求不断增加
      • 越来越多地采用水凝胶和渗透控制药物传输系统
      • 需要提高治疗功效并降低药物毒性以控制各种疾病。
    • 抑制因素
      • 药物输送控制释放系统的复杂製造工艺
    • 机会
      • 奈米技术在先进医学/控制释放药物传输系统製剂的潜在发展
      • 控释药物传输系统的进展
    • 任务
      • 控释药物製剂的潜在局限性
  • 市场区隔分析
    • 释放机制：加强研发力度，发展强大的化学活化系统
    • 技术：整合标靶递送以提高治疗指数并减少副作用
    • 应用：注射缓释性给药系统在慢性病管理中日益普及
  • 市场趋势分析
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法规结构分析
  • 客户客製化

第六章依释放机制控制释放市场

  • 活化调变药物输送系统
  • 化学活化
  • 回馈控制给药系统
  • 微储库分区控制给药系统
  • 基于聚合物的系统

第七章药物输送控制释放市场：依技术分类

  • 凝聚
  • 植入
  • 微胶囊化
  • 定向投放
  • 经皮的
  • 阿尔斯特技术

第八章药物输送控制释放市场：依应用分类

  • 药物释放型支架
  • 点滴帮浦
  • 可注射的
  • 定量吸入器
  • 口服控释给药系统
  • 经皮吸收贴片和眼科贴剂

第 9 章：美洲药物输送控制释放市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太给药控制释放市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲的药物传输控制释放市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • DelSiTech 宣布完成 1,000 万欧元资金筹措，以推进其基于二氧化硅的药物输送技术平台
    • Chiesi 全球罕见疾病与 Aliada Therapeutics 合作推动跨血脑障壁药物传递平台技术

第13章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-A339DAEFA6EE

[196 Pages Report] The Controlled Release Drug Delivery Market size was estimated at USD 43.07 billion in 2023 and expected to reach USD 46.70 billion in 2024, at a CAGR 9.17% to reach USD 79.62 billion by 2030.

Controlled-release drug delivery refers to systems that release the active ingredient of a drug at a predictable and controllable rate. This approach to drug delivery ensures a steady level of medication in the bloodstream, reduces the frequency of dosing, and can improve patient compliance. The market for controlled-release drug delivery is defined by products and technologies that accomplish these objectives across various applications and end-use scenarios. Applications for controlled-release drug delivery span multiple therapeutic areas, such as diabetes, cardiovascular diseases, CNS disorders, pain management, and oncology. Challenges affecting the growth of the controlled-release drug delivery market involve High costs associated with developing new drug delivery systems and Technical challenges in formulating controlled-release drug delivery systems for certain drugs. The market is witnessing the advancement of precision medicine approaches that enable the creation of tailored drug delivery systems for individual patient needs. Additionally, there is an apparent momentum in emerging markets where the expansion of healthcare infrastructures and improved access to pharmaceuticals are generating new opportunities for controlled-release technologies. Furthermore, the landscape is being reshaped by strategic partnerships between pharmaceutical enterprises and drug-delivery technology firms, fostering innovation and the development of sophisticated, more effective drug-delivery mechanisms.

KEY MARKET STATISTICS
Base Year [2023] USD 43.07 billion
Estimated Year [2024] USD 46.70 billion
Forecast Year [2030] USD 79.62 billion
CAGR (%) 9.17%

Release Mechanism: Increasing R&D activities for development of robust chemically activated system

Activation-modulated drug delivery systems are designed to release the drug upon stimulation by external or internal triggers such as magnetic fields, ultrasound, pH changes, or enzymes. These systems offer precise control over the release profile of the drug and are particularly beneficial in targeting specific sites within the body, reducing systemic side effects. Chemically activated systems rely on specific chemical reactions to trigger drug release, such as the presence of certain enzymes or changes in pH levels. These systems are well-suited for gastrointestinal treatments as they can be tailored to activate in different parts of the GI tract. Feedback regulated systems use biological or chemical responses to control drug release. The drug release is adjusted in real-time based on physiological demand, promoting personalized medicine. Such systems usually involve sensors integrated with drug-delivery devices. Micro reservoir systems consist of multiple tiny compartments (reservoirs) containing the drug, which are released at controlled intervals or upon specific triggers. This approach allows for the delivery of multiple drugs with different release profiles and is useful for complex medication regimens. Polymer-based drug delivery systems utilize biodegradable polymers to encase the drug, releasing it slowly as the polymer degrades. These systems offer prolonged release periods and are well-suited for chronic conditions.

Technology: Integration of targeted delivery to increase therapeutic index and reducing side effects

Coacervation is a process that involves the separation of colloidal solutions into two distinct liquid phases: a polymer-rich coacervate phase and a polymer-poor supernatant. This technology is used for encapsulating drugs to protect them from environmental degradation and to control their release. It is preferentially used when the active ingredient is sensitive to degradation and requires a protective barrier. Implants are medical devices designed to release therapeutic agents directly into the site of action over an extended period. They are employed when localized, continuous drug delivery is desired, such as in oncology or hormone replacement therapies. Microencapsulation involves encapsulating tiny particles or droplets with a coating to give small capsules useful properties. Targeted delivery aims to direct the active drug to specific cells or tissues in the body, thereby increasing the therapeutic index and reducing side effects. This technology is preferred for conditions requiring high drug concentrations at the disease site while minimizing systemic exposure, such as in cancer treatments. Transdermal drug delivery systems (TDDS) administer drugs through the skin, providing a non-invasive and convenient alternative to oral and injectable routes. TDDS is typically chosen for chronic disease management where continuous drug administration is advantageous. The Wurster Technique is a subset of fluidized bed coating used extensively in pharmaceuticals for coating granules, pellets, or particles to achieve a controlled release of the drug. This method is well-suited for drugs that require a uniform coating and precise control over the release kinetics.

Application: Rising preference for injectable controlled-release drug delivery systems for chronic disease management

Drug-eluting stents are a remarkable implementation of controlled-release drug delivery used in cardiology. By incorporating medication into the stent's structure, these devices are placed into narrowed, diseased coronary arteries during angioplasty. The drugs are released slowly over time to prevent restenosis, the re-narrowing of the arteries after the procedure. Infusion pumps are medical devices designed to deliver fluids, including nutrients and medications, into a patient's body in a controlled manner. These pumps can be used in a variety of healthcare settings, including hospitals, nursing homes, and even for patients in home care. The ability to control the timing, rate, and duration of delivery helps in maintaining therapeutic drug levels in the bloodstream, which is essential for treatments such as chemotherapy, pain management, and the administration of antibiotics. Injectable controlled release systems offer a sophisticated approach to drug delivery, particularly for systemic effects or targeted therapy. These systems often involve encapsulated drug particles or biodegradable polymers that degrade over time, releasing the drug at a predetermined rate. Metered Dose Inhalers are devices designed to deliver specific amounts of medication to the lungs, commonly used to treat respiratory conditions such as asthma and COPD. The controlled release mechanism in MDIs allows patients to manage their conditions effectively by ensuring precise dosing, rapid onset of action, and reduced systemic side effects compared to systemic administration of the same drugs. Oral controlled-drug delivery systems are one of the most common forms of controlled-release technologies available. They incorporate various formulations such as tablets, capsules, or films that control the rate at which the digestive system releases and absorbs the drug. Transdermal and ocular patches represent a unique controlled-release drug delivery system segment. Transdermal patches administer medication through the skin, allowing for a steady drug release over an extended period, minimizing peak-trough fluctuations and improving patient comfort.

Regional Insights

The controlled-release drug delivery market in the Americas, particularly North America, is well-established due to the presence of key pharmaceutical companies and advanced healthcare infrastructure. The United States holds a significant position in the market, owing to FDA support for novel drug delivery systems and a higher prevalence of chronic diseases, which necessitate prolonged drug administration. Europe holds a substantial share in the controlled release drug delivery market, with a strong regulatory framework governed by the European Medicines Agency (EMA). The market benefits from favorable government healthcare policies and the rise of generics due to patent cliffs. The Middle East and Africa exhibit potential growth due to economic development, investment in healthcare infrastructure, and increasing accessibility to advanced treatment options. Asia-Pacific is expected to experience rapid growth in the controlled-release drug delivery sector due to the expanding pharmaceutical industry and rising healthcare expenditure in countries such as China and India. There is an increasing focus on addressing the unmet medical needs of a large patient population. Partnerships between local and international players and governmental support in promoting generic drug use offer growth opportunities in this region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Controlled Release Drug Delivery Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Controlled Release Drug Delivery Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Controlled Release Drug Delivery Market, highlighting leading vendors and their innovative profiles. These include Adare Pharma Solutions, Alkermes PLC, AMW GmbH, AstraZeneca PLC, Avantor, Inc., Baxter International Inc., Becton, Dickinson and Company, Biogen Inc., Boehringer Ingelheim International GmbH, Catalent, Inc., Celanese Corporation, Celares GmbH, Coating Place, Inc., Collegium Pharmaceutical, Inc., Colorcon, Inc., Corium, Inc., CURE Pharmaceutical, GlaxoSmithKline PLC, Insulet Corporation, Johnson & Johnson Services, Inc., Lonza Group Ltd., Medtronic PLC, Merck & Co., Inc., Pensatech Pharma GmbH, Pfizer Inc., Seqens, Tandem Diabetes Care, Inc., and Trelleborg AB.

Market Segmentation & Coverage

This research report categorizes the Controlled Release Drug Delivery Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Release Mechanism
    • Activation-Modulated Drug Delivery Systems
      • Hydrodynamic Pressure Activated
      • Magnetically Activated
      • Mechanically Activated
      • Osmotic Pressure Activated
      • Vapor Pressure Activated
    • Chemically Activated
      • Enzyme Activated
      • Hydrolysis Activated
      • pH Activated
    • Feedback Regulated Drug Delivery Systems
    • Micro Reservoir Partition Controlled Drug Delivery Systems
    • Polymer Based Systems
  • Technology
    • Coacervation
    • Implants
    • Micro Encapsulation
    • Targeted Delivery
    • Transdermal
    • Wurster Technique
  • Application
    • Drug Eluting Stents
    • Infusion Pumps
    • Injectable
    • Metered Dose Inhalers
    • Oral Controlled-Drug Delivery Systems
    • Transdermal & Ocular Patches
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Controlled Release Drug Delivery Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Controlled Release Drug Delivery Market?

3. What are the technology trends and regulatory frameworks in the Controlled Release Drug Delivery Market?

4. What is the market share of the leading vendors in the Controlled Release Drug Delivery Market?

5. Which modes and strategic moves are suitable for entering the Controlled Release Drug Delivery Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in Need for Controlled Release Dosage Forms for the Infants and Geriatric Population
      • 5.1.1.2. Rising Adoption of Hydrogel and Osmotic Controlled Drug Delivery System
      • 5.1.1.3. Need to Improve the Therapeutic Benefits, Reduce Drug Toxicity to Control Various Types of Illness
    • 5.1.2. Restraints
      • 5.1.2.1. Complex Manufacturing Process of Controlled Release Drug Delivery System
    • 5.1.3. Opportunities
      • 5.1.3.1. Potential Development of Nanotechnology in Advanced Medicine/Drug Formulations for Controlled-Release Drug Delivery System
      • 5.1.3.2. Advances in Control Release Drug Delivery System
    • 5.1.4. Challenges
      • 5.1.4.1. Potential limitation of controlled drug release formulation
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Release Mechanism: Increasing R&D activities for development of robust chemically activated system
    • 5.2.2. Technology: Integration of targeted delivery to increase therapeutic index and reducing side effects
    • 5.2.3. Application: Rising preference for injectable controlled-release drug delivery systems for chronic disease management
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework Analysis
  • 5.9. Client Customization

6. Controlled Release Drug Delivery Market, by Release Mechanism

  • 6.1. Introduction
  • 6.2. Activation-Modulated Drug Delivery Systems
  • 6.3. Chemically Activated
  • 6.4. Feedback Regulated Drug Delivery Systems
  • 6.5. Micro Reservoir Partition Controlled Drug Delivery Systems
  • 6.6. Polymer Based Systems

7. Controlled Release Drug Delivery Market, by Technology

  • 7.1. Introduction
  • 7.2. Coacervation
  • 7.3. Implants
  • 7.4. Micro Encapsulation
  • 7.5. Targeted Delivery
  • 7.6. Transdermal
  • 7.7. Wurster Technique

8. Controlled Release Drug Delivery Market, by Application

  • 8.1. Introduction
  • 8.2. Drug Eluting Stents
  • 8.3. Infusion Pumps
  • 8.4. Injectable
  • 8.5. Metered Dose Inhalers
  • 8.6. Oral Controlled-Drug Delivery Systems
  • 8.7. Transdermal & Ocular Patches

9. Americas Controlled Release Drug Delivery Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Controlled Release Drug Delivery Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Controlled Release Drug Delivery Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. DelSiTech Announces Closing of EUR 10 Million Financing Round to Advance its Silica-Based Drug Delivery Technology Platform
    • 12.3.2. Chiesi Global Rare Diseases and Aliada Therapeutics Partner to Advance Blood-Brain Barrier-Crossing Platform Technology for Drug Delivery

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. CONTROLLED RELEASE DRUG DELIVERY MARKET RESEARCH PROCESS
  • FIGURE 2. CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CONTROLLED RELEASE DRUG DELIVERY MARKET DYNAMICS
  • FIGURE 7. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. CONTROLLED RELEASE DRUG DELIVERY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. CONTROLLED RELEASE DRUG DELIVERY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CONTROLLED RELEASE DRUG DELIVERY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY HYDRODYNAMIC PRESSURE ACTIVATED, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY HYDRODYNAMIC PRESSURE ACTIVATED, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MAGNETICALLY ACTIVATED, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MAGNETICALLY ACTIVATED, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MECHANICALLY ACTIVATED, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MECHANICALLY ACTIVATED, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY OSMOTIC PRESSURE ACTIVATED, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY OSMOTIC PRESSURE ACTIVATED, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY VAPOR PRESSURE ACTIVATED, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY VAPOR PRESSURE ACTIVATED, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ENZYME ACTIVATED, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ENZYME ACTIVATED, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY HYDROLYSIS ACTIVATED, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY HYDROLYSIS ACTIVATED, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY PH ACTIVATED, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY PH ACTIVATED, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY FEEDBACK REGULATED DRUG DELIVERY SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY FEEDBACK REGULATED DRUG DELIVERY SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICRO RESERVOIR PARTITION CONTROLLED DRUG DELIVERY SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICRO RESERVOIR PARTITION CONTROLLED DRUG DELIVERY SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY POLYMER BASED SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY POLYMER BASED SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COACERVATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COACERVATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY IMPLANTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY IMPLANTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICRO ENCAPSULATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICRO ENCAPSULATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TARGETED DELIVERY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TARGETED DELIVERY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY WURSTER TECHNIQUE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY WURSTER TECHNIQUE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DRUG ELUTING STENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DRUG ELUTING STENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY INJECTABLE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 61. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY METERED DOSE INHALERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 62. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY METERED DOSE INHALERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 63. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ORAL CONTROLLED-DRUG DELIVERY SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 64. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ORAL CONTROLLED-DRUG DELIVERY SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 65. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL & OCULAR PATCHES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 66. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL & OCULAR PATCHES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 67. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 68. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 69. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 70. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 71. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
  • TABLE 72. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
  • TABLE 73. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 74. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 75. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 76. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 77. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 78. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 79. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 80. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 81. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 82. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 83. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
  • TABLE 84. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
  • TABLE 85. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 86. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 87. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 88. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 89. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 90. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 91. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 92. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 93. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
  • TABLE 94. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
  • TABLE 95. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 96. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 97. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 98. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 99. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 100. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 101. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 102. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 103. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
  • TABLE 104. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
  • TABLE 105. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 106. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 107. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 108. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 109. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 110. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 111. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 112. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 113. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
  • TABLE 114. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
  • TABLE 115. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 116. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 117. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 118. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 119. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 120. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 121. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 122. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 123. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
  • TABLE 124. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
  • TABLE 125. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 126. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 127. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 128. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 129. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 130. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 143. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 144. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 145. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 146. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 147. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
  • TABLE 148. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
  • TABLE 149. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 150. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 151. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 152. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 153. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 154. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 155. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 156. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 157. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
  • TABLE 158. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
  • TABLE 159. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 160. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 161. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 162. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 163. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 164. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 165. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 166. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 167. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
  • TABLE 168. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
  • TABLE 169. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 170. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 171. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 172. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 173. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 174. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 175. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 176. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 177. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
  • TABLE 178. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
  • TABLE 179. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 180. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 181. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 182. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 183. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 184. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 185. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 186. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 187. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
  • TABLE 188. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
  • TABLE 189. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 190. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 191. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 192. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 193. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 194. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 195. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 196. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 197. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
  • TABLE 198. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
  • TABLE 199. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 200. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 201. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 202. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 203. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 204. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 205. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 206. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 207. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
  • TABLE 208. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
  • TABLE 209. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 210. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 211. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 212. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 213. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 214. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 215. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 216. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 217. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
  • TABLE 218. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
  • TABLE 219. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 220. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 221. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 222. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 223. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 224. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 225. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 226. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 227. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
  • TABLE 228. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
  • TABLE 229. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 230. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 231. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 232. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 233. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 234. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 235. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 236. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 237. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
  • TABLE 238. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
  • TABLE 239. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 240. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 241. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 242. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 243. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 244. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 245. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 246. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 247. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
  • TABLE 248. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
  • TABLE 249. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 250. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 251. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 252. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 253. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 254. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 255. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 256. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 257. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
  • TABLE 258. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
  • TABLE 259. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 260. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 261. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 262. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 275. DENMARK CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 276. DENMARK CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 277. DENMARK CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 278. DENMARK CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 279. DENMARK CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
  • TABLE 280. DENMARK CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
  • TABLE 281. DENMARK CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLIO